BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21418619)

  • 1. Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule.
    Calvo AC; Moreno-Igoa M; Mancuso R; Manzano R; Oliván S; Muñoz MJ; Penas C; Zaragoza P; Navarro X; Osta R
    Orphanet J Rare Dis; 2011 Mar; 6():10. PubMed ID: 21418619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy.
    Moreno-Igoa M; Calvo AC; Penas C; Manzano R; Oliván S; Muñoz MJ; Mancuso R; Zaragoza P; Aguilera J; Navarro X; Osta Pinzolas R
    J Mol Med (Berl); 2010 Mar; 88(3):297-308. PubMed ID: 19921501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-1:tetanus toxin fragment C fusion protein improves delivery of IGF-1 to spinal cord but fails to prolong survival of ALS mice.
    Chian RJ; Li J; Ay I; Celia SA; Kashi BB; Tamrazian E; Matthews JC; Bronson RT; Rossomando A; Pepinsky RB; Fishman PS; Brown RH; Francis JW
    Brain Res; 2009 Sep; 1287():1-19. PubMed ID: 19563785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model.
    Ciriza J; Moreno-Igoa M; Calvo AC; Yague G; Palacio J; Miana-Mena FJ; Muñoz MJ; Zaragoza P; Brûlet P; Osta R
    Restor Neurol Neurosci; 2008; 26(6):459-65. PubMed ID: 19096133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-viral gene delivery of the GDNF, either alone or fused to the C-fragment of tetanus toxin protein, prolongs survival in a mouse ALS model.
    Moreno-Igoa M; Calvo AC; Ciriza J; Muñoz MJ; Zaragoza P; Osta R
    Restor Neurol Neurosci; 2012; 30(1):69-80. PubMed ID: 22124037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Fragment C of Tetanus Toxin Modulates IL-6 in an ALS Mouse Model.
    Moreno-Martinez L; de la Torre M; Muñoz MJ; Zaragoza P; Aguilera J; Calvo AC; Osta R
    Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32429516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
    Kim J; Kim TY; Cho KS; Kim HN; Koh JY
    Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor facilitates in vivo internalization of tetanus neurotoxin C-terminal fragment fusion proteins in mature mouse motor nerve terminals.
    Roux S; Saint Cloment C; Curie T; Girard E; Miana Mena FJ; Barbier J; Osta R; Molgó J; Brûlet P
    Eur J Neurosci; 2006 Sep; 24(6):1546-54. PubMed ID: 17004918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice.
    Larsen KE; Benn SC; Ay I; Chian RJ; Celia SA; Remington MP; Bejarano M; Liu M; Ross J; Carmillo P; Sah D; Phillips KA; Sulzer D; Pepinsky RB; Fishman PS; Brown RH; Francis JW
    Brain Res; 2006 Nov; 1120(1):1-12. PubMed ID: 17020749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression, purification of tetanus toxin C fragment/cardiotrophin-1 recombinant fusion protein, target delivery to CNS and neurotrophy biology ability].
    Chen C; Wang J; Yang P; Zhou Y; Zhang ZF
    Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):202-5. PubMed ID: 19563075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific Expression of Glial-Derived Neurotrophic Factor in Muscles as Gene Therapy Strategy for Amyotrophic Lateral Sclerosis.
    Mòdol-Caballero G; García-Lareu B; Herrando-Grabulosa M; Verdés S; López-Vales R; Pagès G; Chillón M; Navarro X; Bosch A
    Neurotherapeutics; 2021 Apr; 18(2):1113-1126. PubMed ID: 33786805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
    Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
    J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal targeting of cardiotrophin-1 by coupling with tetanus toxin C fragment.
    Bordet T; Castelnau-Ptakhine L; Fauchereau F; Friocourt G; Kahn A; Haase G
    Mol Cell Neurosci; 2001 May; 17(5):842-54. PubMed ID: 11358482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetanus toxin fragment C fusion facilitates protein delivery to CNS neurons from cerebrospinal fluid in mice.
    Benn SC; Ay I; Bastia E; Chian RJ; Celia SA; Pepinsky RB; Fishman PS; Brown RH; Francis JW
    J Neurochem; 2005 Nov; 95(4):1118-31. PubMed ID: 16271047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Zhao Z; Fu J; Li S; Li Z
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):688-696. PubMed ID: 31321663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for overexpressing Neuregulin 1 type I in skeletal muscles promotes functional improvement in the SOD1
    Mòdol-Caballero G; Herrando-Grabulosa M; García-Lareu B; Solanes N; Verdés S; Osta R; Francos-Quijorna I; López-Vales R; Calvo AC; Bosch A; Navarro X
    Neurobiol Dis; 2020 Apr; 137():104793. PubMed ID: 32032731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-Derived Neurotrophic Factor Facilitates Functional Recovery from ALS-Cerebral Spinal Fluid-Induced Neurodegenerative Changes in the NSC-34 Motor Neuron Cell Line.
    Shruthi S; Sumitha R; Varghese AM; Ashok S; Chandrasekhar Sagar BK; Sathyaprabha TN; Nalini A; Kramer BW; Raju TR; Vijayalakshmi K; Alladi PA
    Neurodegener Dis; 2017; 17(1):44-58. PubMed ID: 27617773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.